レコードの引用形

APA(7版)引用形式
Conley, A. C., Key, A. P., Blackford, J. U., Russell, J. K., Albert, K. M., Gong, X., . . . Newhouse, P. A. (2025). Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer’s disease: A single ascending-dose study in healthy participants. BMC.
Chicagoスタイル(17版)引用形式
Conley, Alexander C., et al. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M1 Positive Allosteric Modulator VU0467319 for Alzheimer’s Disease: A Single Ascending-dose Study in Healthy Participants. BMC, 2025.
MLA(9版)引用形式
Conley, Alexander C., et al. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M1 Positive Allosteric Modulator VU0467319 for Alzheimer’s Disease: A Single Ascending-dose Study in Healthy Participants. BMC, 2025.
警告: この引用は必ずしも正確ではありません.